跳至主要内容
临床试验/NCT04423848
NCT04423848终止不适用

Supportive Oncology Care at Home Intervention for Patients With Lymphoma

Massachusetts General Hospital2 个研究点 分布在 1 个国家目标入组 3 人开始时间: 2020年6月1日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
3
试验地点
2
主要终点
enrollment rate

研究概览

简要总结

The goal of this research is to evaluate an intervention, which the investigators call "Home Hospital for Lymphoma," that involves remote patient monitoring and home-based supportive care for patients hospitalized with lymphoma at Massachusetts General Hospital.

详细描述

This research study is a single arm pilot Feasibility Study, which is the first-time investigators are examining this hospital at home intervention for patients with lymphoma.

The research study procedures include screening for eligibility, questionnaires, remote patient monitoring (e.g. patient-reported symptoms and home monitored vital signs) and home-based supportive care (e.g. visits to patients' homes to address and manage any concerning issues identified), and interviews of participants, caregivers, and clinicians asking their perceptions of the Home Hospital for Lymphoma program.

Participants will include 3 groups:

Enrolled participants receiving the hospital at home intervention, caregivers of participants, and clinicians.

Participants will be in the research study for about six months after consent. It is expected that up to 38 participants will take part in this research study.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 18 or older
  • Receiving their lymphoma care with curative intent at MGH (treatment intent based upon chemotherapy order in the electronic medical record)
  • Hemodynamically stable during the first 24 hours of hospital admission at MGH
  • Residing within the designated geographic area for MGH Home Hospital Service (an approximately 10-mile radius from MGH)
  • Able to communicate and respond to questionnaires in English
  • Lives with a family member or a friend who supports the patient at home
  • Deemed eligible for supportive oncology care at home based on the MGH Home Hospital clinician evaluation

排除标准

  • Those admitted to the intensive care unit
  • Have high oxygen requirement (FIO2 > 0.4)
  • Experience active angina or cardiac arrythmias
  • Have a planned inpatient surgical or interventional procedure
  • Have uncontrolled psychiatric illness or impaired cognition that prohibits complying with the study procedures
  • Have uncontrolled pain requiring intravenous pain medications
  • Those deemed ineligible based on the Home Hospital Service clinician evaluation

结局指标

主要结局

enrollment rate

时间窗: 1 year

The primary endpoint is feasibility. The proposed intervention will be deemed feasible if at least 60% of eligible patients are enrolled in the study

retention rate

时间窗: 1 year

The primary endpoint is feasibility. The proposed intervention will be deemed feasible if those enrolled patients complete at least 60% of daily patient-reported symptom assessment.

次要结局

  • Rates of completion of daily vital signs(1 year)
  • Acceptability of the intervention(1 year)
  • Rates of Adverse Events(1 year)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

El-Jawahri, Areej,M.D.

Principal Investigator

Massachusetts General Hospital

研究点 (2)

Loading locations...

相似试验